References
- Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102 : 433-41. https://doi.org/10.1016/j.tripleo.2006.06.004
- Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg 2010; 38 : 255-9. https://doi.org/10.1016/j.jcms.2009.06.005
- Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 2007; 28 : 158-63. https://doi.org/10.1016/j.amjoto.2006.08.004
- Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, et al. Normal serum bone markers in bisphosphonate- induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106 : 389-91. https://doi.org/10.1016/j.tripleo.2008.01.033
- Campisi G, Di Fede O, Musciotto A, Lo Casto A, Lo Muzio L, Fulfaro F, et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol 2007; 18 Suppl 6 : vi168-72. https://doi.org/10.1093/annonc/mdm250
- Morag Y, Morag-Hezroni M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, et al. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics 2009; 29 : 1971-84. https://doi.org/10.1148/rg.297095050
- Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 2011; 1218 : 38-46. https://doi.org/10.1111/j.1749-6632.2010.05768.x
- Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol 2007; 1 : 132-40. https://doi.org/10.1007/s12105-007-0033-2
- Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61 : 1115-7. https://doi.org/10.1016/S0278-2391(03)00720-1
- Ortega C, Montemurro F, Faggiuolo R, Vormola R, Nanni D, Goia F, et al. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta Oncol 2007; 46 : 664-8. https://doi.org/10.1080/02841860601185917
- Conte-Neto N, Bastos AS, Spolidorio LC, Marcantonio RA, Marcantonio E Jr. Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports. Head Face Med 2011; 7 : 7. https://doi.org/10.1186/1746-160X-7-7
- Abughazaleh K, Kawar N. Osteonecrosis of the jaws: what the physician needs to know: practical considerations. Dis Mon 2011; 57 : 231-41. https://doi.org/10.1016/j.disamonth.2011.03.011
Cited by
- Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors vol.31, pp.2, 2011, https://doi.org/10.1200/jco.2012.43.6733
- Denosumab, a RANKL Inhibitor, Induced Osteonecrosis of the Jaw vol.3, pp.1, 2011, https://doi.org/10.12677/hjs.2013.31001
- Denosumab Related Osteonecrosis of Jaw: a Case Report vol.9, pp.4, 2018, https://doi.org/10.5037/jomr.2018.9405